Rudolph M Navari Selected Research

netupitant

10/2023	Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
8/2021	Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.
12/2019	The safety of rolapitant for the treatment of nausea and vomiting associated with chemotherapy.
1/2018	Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting.
1/2016	The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.
1/2015	Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV).
1/2015	Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudolph M Navari Research Topics

Disease

69	Vomiting 12/2023 - 06/2002
67	Nausea 12/2023 - 07/2003
24	Neoplasms (Cancer) 01/2023 - 05/2003
6	Motion Sickness (Airsickness) 07/2010 - 07/2003
5	Hypersensitivity (Allergy) 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2008
3	Fatigue 01/2020 - 09/2015
3	Headache (Headaches) 01/2016 - 09/2015
3	Constipation 01/2016 - 09/2015
2	Injection Site Reaction 01/2021 - 01/2018
2	Anaphylaxis (Anaphylactic Shock) 01/2019 - 01/2018
2	Hiccup (Hiccups) 01/2016 - 09/2015
2	Neutropenia 09/2015 - 09/2015
2	Postoperative Nausea and Vomiting (PONV) 07/2008 - 09/2003
2	Infections 08/2005 - 05/2003
1	Dyspnea (Shortness of Breath) 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2016
1	Esophageal Neoplasms (Esophageal Cancer) 04/2016
1	Diarrhea 01/2016
1	Dyspepsia (Indigestion) 09/2015
1	Schizophrenia (Dementia Praecox) 01/2014
1	Delirium 01/2014
1	Diabetes Mellitus 01/2014
1	Weight Gain 01/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2011
1	Hemorrhage 09/2011
1	Wounds and Injuries (Trauma) 09/2011
1	Endotoxemia 01/2011
1	Protein C Deficiency 01/2011
1	Anorexia 08/2010

Drug/Important Bio-Agent (IBA)

27	Olanzapine (Zyprexa)FDA Link 12/2023 - 01/2004
26	AntiemeticsIBA 01/2023 - 06/2002
23	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 06/2002
16	Aprepitant (Emend)FDA Link 08/2021 - 06/2002
15	Neurokinin-1 Receptor AntagonistsIBA 02/2020 - 06/2002
12	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021 - 07/2003
11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 06/2002
10	Palonosetron (Aloxi)FDA Link 10/2019 - 11/2007
10	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 06/2002
9	fosaprepitant FDA Link 01/2023 - 12/2007
8	rolapitantIBA 12/2019 - 01/2015
7	netupitantIBA 10/2023 - 01/2015
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 01/2004
6	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2023 - 01/2004
4	AnthracyclinesIBA 10/2023 - 09/2015
4	Antipsychotic Agents (Antipsychotics)IBA 06/2017 - 03/2013
3	Polysorbates (PSML)FDA Link 01/2019 - 01/2018
3	Substance PIBA 01/2017 - 01/2004
3	Metoclopramide (Reglan)FDA LinkGeneric 01/2017 - 06/2013
3	Ondansetron (Zofran)FDA LinkGeneric 09/2006 - 06/2002
2	EmulsionsIBA 02/2020 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 07/2018
2	TabletsIBA 01/2018 - 06/2002
2	EmeticsIBA 01/2017 - 09/2006
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 10/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2005 - 01/2004
1	diadenosine pyrophosphate (AppA)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	ProdrugsIBA 01/2018
1	Excipients (Suspending Agents)IBA 01/2018
1	SuspensionsIBA 01/2018
1	Carmustine (FIVB)FDA Link 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2015
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2015
1	Dopamine (Intropin)FDA LinkGeneric 10/2015
1	Ion Channels (Ion Channel)IBA 10/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2015
1	Catecholamine ReceptorsIBA 10/2015
1	Serotonin ReceptorsIBA 10/2015
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2015
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 10/2015
1	Antineoplastic Agents (Antineoplastics)IBA 09/2015
1	palosentron drug combination netupitantIBA 01/2015
1	TachykininsIBA 01/2014
1	recombinant FVIIa (rFVIIa)FDA Link 09/2011
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2011
1	Thromboplastin (Tissue Factor)IBA 01/2011
1	LipopolysaccharidesIBA 01/2011
1	Thrombin FDA Link 01/2011
1	Factor VIIa (Activated Factor VII)IBA 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	Protein CIBA 01/2011
1	Megestrol Acetate (Borea)FDA LinkGeneric 08/2010
1	Estrogens (Estrogen)FDA Link 11/2008

Therapy/Procedure

70	Drug Therapy (Chemotherapy) 12/2023 - 07/2003
7	Therapeutics 08/2021 - 06/2002
4	Radiotherapy 01/2020 - 04/2016
2	Injections 02/2020 - 01/2019
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2014 - 03/2013
2	Hospice Care (Care, Bereavement) 08/2005 - 05/2003
1	Aftercare (After-Treatment) 09/2015
1	Resuscitation 09/2011